DAY-301

N/A

Report date: 2025/04/30 16:00:54
First In Class

Base Information

Drug NameDAY-301
Drug Alias NameDAY301DAY-301MTX-13CB-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-PTK7
TargetsProtein-tyrosine kinase 7
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Mycos Biomedicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDay One Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A